23.4 C
New York
Monday, June 15, 2026

Tag: interactions

The Brain Song Uses a Nasa-Inspired Gamma Wave Formula to Stimulate BDNF and Enhance Memory in 2025

Binaural Technologies’ The Brain Song offers a 17-minute gamma brainwave and BDNF support audio program for adults seeking natural memory, focus, and cognitive resilience without pills or complex routines in 2025.
Binaural Technologies’ The Brain Song offers a 17-minute gamma brainwave and BDNF support audio program for adults seeking natural memory, focus, and cognitive resilience without pills or complex routines in 2025.

Functional Foods Market Surges to USD 654.45 Billion by 2033, Propelled by 10.4% CAGR – Verified Market Reports®

The Functional Foods Market is experiencing robust expansion, driven by rising consumer focus on health, wellness, and preventive nutrition. Growing demand for nutrient-enriched products,...

Functional Foods Market Surges to USD 654.45 Billion by 2033, Propelled by 10.4% CAGR – Verified Market Reports®

The Functional Foods Market is experiencing robust expansion, driven by rising consumer focus on health, wellness, and preventive nutrition. Growing demand for nutrient-enriched products,...

GPT-5 Needs a Heart, Not Just a CPU

ChatGPT's latest update is making waves for its shift from a chipper tone to a more businesslike demeanor. This isn't exactly earth-shattering news for...

Renewal by Andersen Ranks Highest in J.D. Power 2025 U.S. Windows and Patio Doors Satisfaction Study(SM), Continuing A Legacy as Most Awarded Brand for...

COTTAGE GROVE, Minn., Aug. 13, 2025 /PRNewswire/ -- Renewal by Andersen has once again earned top honors in customer satisfaction, ranking "#1 in customer satisfaction with...

Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT – Advancing Breakthrough Therapy for Chronic Lower Back Pain

PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on regenerative and immune cellular therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead investigational therapy, CELZ-201-DDT, for the treatment of degenerative disc disease (DDD), a major cause of chronic lower back pain and disability.

AI and the Empathy Gap: Finding the Balance between AI and Human First Customer Experience

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- While brands are celebrating AI-driven efficiency gains in customer experience (CX), a significant gap exists between their internal benefits and the often underwhelming service that consumers are actually experiencing. According to Verizon’s CX Annual Insights report, the future of CX isn't just about implementing AI, but about strategically integrating it to amplify human connections and address core customer frustrations.

TeleVox Awarded National Patient Access and Engagement Software Agreement with Premier, Inc.

OMAHA, Neb., Aug. 12, 2025 (GLOBE NEWSWIRE) -- TeleVox, the industry-leading provider of omnichannel patient relationship management, announced a new national group purchasing agreement with Premier, Inc., a leading healthcare improvement company serving over two-thirds of U.S. providers. Effective September 1, 2025, the agreement enables Premier members, at their discretion, to access pre-negotiated pricing and terms for TeleVox’s industry-leading solutions, including Digital Front Door, Appointment Management, Digital Care Programs, and Patient Marketing.

LightPath Technologies Appoints Respected Photonics Veteran Stephen Mielke, Ph.D., as Vice President of Engineering

Former Luminar Optical Engineering Executive to Spearhead LightPath's Transition from Component to System Supplier ORLANDO, Fla., Aug. 12, 2025 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:...

Netskope Recognized for Continued Leadership in Both SASE and SSE

Recent enhancements to Netskope One SASE help organizations from midmarket to large enterprise modernize for the cloud and AI era SANTA CLARA, Calif., Aug. 12,...

China Literature Announces 2025 Interim Results

HONG KONG, Aug. 12, 2025 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual...

TextMagic AS 2025 6 months consolidated unaudited interim report

In the first half of 2025, revenue amounted to €7,115 thousand (H1 2024: €7,809 thousand). The decline was mainly due to a more competitive pricing strategy that was implemented on the Textmagic platform. EBITDA was €2,581 thousand (H1 2024: €3,149 thousand), and the operating loss totaled to €123 thousand (H1 2024: operating profit of €1,097 thousand). Profitability was negatively affected by an increase in amortization expenses of €652 thousand, resulting from the higher volume of development activities in previous periods with the goal of improving the value proposition.

Singapore Witnesses the Future of Logistics Unfold at GoComet’s Odyssey 2025

Supply chain leaders gathered to experience intelligent technology and envision resilient supply chains. SINGAPORE, Aug. 12, 2025 /PRNewswire/ -- At a time when global logistics...

LivePerson Announces Deleveraging Transaction

Enters into agreement to exchange $341.1 million of its outstanding 2026 Convertible Senior Notes for $45.0 million in cash, $115.0 million of 2029 Senior...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInteractions